Thread Embedding Acupuncture Combined With Auricular Acupuncture for

Status Completed

Clinical Trial Summary

Overweight and obesity are chronic non-communicable diseases with a rapidly increasing global prevalence. They constitute risk factors for various chronic conditions, including cardiovascular diseases, type 2 diabetes, chronic kidney disease, cancer, as well as musculoskeletal disorders and numerous other disorders, significantly impacting the quality of life. Numerous non-pharmacological interventions have been employed in the management of these conditions. Particularly, Auricular acupuncture (AA) has been a widely used and established method for weight management, owing to its effectiveness, safety, and convenience. Recently, a novel therapy known as Thread embedding acupuncture (TEA) has also demonstrated efficacy in weight reduction. Several studies have shown a substantial increase in treatment effectiveness when combining TEA with other acupuncture therapies. However, there is currently no available data on the combination of TEA with AA. This study is conducted to assess the efficacy and safety of combining TEA with AA compared with AA monotherapy in overweight and obesity.

Clinical Trial Description

Eligible participants with overweight or obesity, defined according to the criteria set by The World Health Organization Regional Office for the Western Pacific Region (Body Mass Index [BMI] of 23 kg/m² or higher), will be enrolled and subsequently randomized into two groups: the intervention group (AA + TEA group) and the placebo group (AA + Sham-TEA group), with a 1:1 allocation ratio. In both groups, the intervention duration is eight weeks, with Auricular acupuncture (AA) administered weekly, along with recommended lifestyle modifications. For the intervention group, Thread embedding acupuncture (TEA) therapy will be added every two weeks, totaling four sessions during the eight-week period. Meanwhile, Sham-TEA will be administered in the placebo group. Data regarding body weight, BMI, waist circumference, hip circumference, appetite, and adverse effects will be recorded immediately following randomization and weekly thereafter over the eight-week duration. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06091761
Study type	Interventional
Source	University of Medicine and Pharmacy at Ho Chi Minh City
Contact
Status	Completed
Phase	N/A
Start date	October 30, 2023
Completion date	March 21, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06013163` - A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers	Phase 1
Active, not recruiting	`NCT03843424` - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers	N/A
Not yet recruiting	`NCT06360536` - Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women	N/A
Not yet recruiting	`NCT05997576` - A Study of TG103 Injection in Non-diabetic Overweight or Obesity	Phase 3
Recruiting	`NCT04763291` - Cardiovascular and InflammAging Study	N/A
Active, not recruiting	`NCT04399460` - The Effects of Long-term Consumption of Full-fat Dairy Products on Satiety, Body Weight and Glycemic Control	N/A
Completed	`NCT04451824` - Examination of Circumferential Reduction	N/A
Completed	`NCT04110717` - Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight	N/A
Completed	`NCT05561855` - T2DM Intensity Lifestyle Intervention	N/A
Active, not recruiting	`NCT04100200` - Berries, Inflammation, and Gut Microbiome	N/A
Recruiting	`NCT06125964` - eMOTION Formative Study	N/A
Recruiting	`NCT06087822` - Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21®	N/A
Active, not recruiting	`NCT04328233` - Impact of Time-Restricted Eating on Metabolic Homeostasis, Inflammation and Oxidative Stress in Metabolic Syndrome	N/A
Completed	`NCT04894344` - Education to Decrease in Sodium Intake Evaluated With 24 Hour Urinary Sodium Excretion (RCT)	N/A
Completed	`NCT05713461` - Physical Exercise in Obesity for Health and Quality of Life.	N/A
Not yet recruiting	`NCT06054698` - Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects	Phase 2
Not yet recruiting	`NCT02823912` - Capsaicin Effect on Cytokines Profile in Dyslipidemia	Phase 2/Phase 3
Completed	`NCT05104151` - Efficacy of a Nutritive Bar, in Reduction of Weight, Body Fat and Control of Appetite	N/A
Completed	`NCT04786925` - Precision Nutrition Strategies for Improving the Quality of Life of Pre-senior and Senior Populations	N/A
Enrolling by invitation	`NCT06092632` - Efficacy of Pigmented Rice on Reducing Cardiometabolic Risk Factors Among Filipino Adults	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Thread Embedding Acupuncture Combined With Auricular Acupuncture for Overweight and Obesity

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms